Items in cart [0] Questions? Call 888-624-8373

PAPERBACK + PDF your price: $46.00 add to cart PAPERBACK list:$39.00 Web:$35.10 add to cart PDF BOOK your price: $30.00 add to cart PDF CHAPTERS your price: $3.80 select Rights & Permissions Free Resources PDF Report Brief PDF EXECUTIVE SUMMARY Display this book on your site! Related Titles From Cancer Patient to Cancer Survivor: Lost in Transition Monitoring Metabolic Status: Predicting Decrements in Physiological and Cognitive Performance Other Related Titles Testosterone and Aging: Clinical Research Directions (2004) Board on Health Sciences Policy (HSP) Institute of Medicine (IOM) Web Search Builder Use this book's key terms to search within this book, across our collection, or across the Web. Skim This Chapter Skim this chapter and use this chapter's key terms to search within this book. Reference Finder Paste in your own text to find books that relate to your topic. Page 202   E-mail  Facebook  Digg  Stumble  Twitter More The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy. E Acronyms AACE American Association of Clinical Endocrinologists ADL activities of daily living AIDS acquired immunodeficiency syndrome AR androgen receptor AUA American Urological Association AUR acute urinary retention BDI Beck Depression Inventory BLSA Baltimore Longitudinal Study of Aging BMD bone mineral density BMI body mass index BOP N-nitrosobis(2-oxypropyl)amine BP blood pressure BPH benign prostatic hypertrophy BT bioavailable testosterone CAD coronary artery disease CGI Clinical Global Impression score CI confidence interval DBP diastolic blood pressure DHEA dehydroepiandrosterone DHEAS dehydroepiandrosterone-sulfate DHT dihydrotestosterone DRE digital rectal examination Page 202 Front Matter (R1-R18) Executive Summary (1-10) 1 Introduction (11-31) 2 Testosterone and Health Outcomes (32-111) 3 Future Research Directions (112-158) 4 Concluding Remarks (159-164) Appendix A: Data Sources and Methods (165-172) Appendix B: Randomized Placebo-Controlled Trials of Testosterone Therapy in Older Men (173-181) Appendix C: Additional Studies of Testosterone Therapy (182-197) Appendix D: Testosterone Levels in Clinical Studies (198-201) Appendix E: Acronyms (202-204) Appendix F: Biographical Sketches of Committee Members and Staff (205-210) Index (211-220)

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 202
Testosterone and Aging: Clinical Research Directions E Acronyms AACE American Association of Clinical Endocrinologists ADL activities of daily living AIDS acquired immunodeficiency syndrome AR androgen receptor AUA American Urological Association AUR acute urinary retention BDI Beck Depression Inventory BLSA Baltimore Longitudinal Study of Aging BMD bone mineral density BMI body mass index BOP N-nitrosobis(2-oxypropyl)amine BP blood pressure BPH benign prostatic hypertrophy BT bioavailable testosterone CAD coronary artery disease CGI Clinical Global Impression score CI confidence interval DBP diastolic blood pressure DHEA dehydroepiandrosterone DHEAS dehydroepiandrosterone-sulfate DHT dihydrotestosterone DRE digital rectal examination

OCR for page 203
Testosterone and Aging: Clinical Research Directions E2 estradiol ED erectile dysfunction ESTEEM Efficacy and Safety of Testosterone in Elderly Men Trial FDA Food and Drug Administration FICSIT Frailty and Injuries: Cooperative Studies of Intervention Techniques FIM Functional Independence Measure FSFI Female Sexual Function Index FSH follicle stimulating hormone FT free testosterone FTI free testosterone index GDS-SF Geriatric Depression Score Short Form GH growth hormone GnRH gonadotropin-releasing hormone Ham-D Hamilton Depression Rating Scale HDL high-density lipoprotein HIV human immunodeficiency virus HRQoL health-related quality of life IADL instrumental activities of daily living IGF insulin-like growth factor IGFBP insulin-like growth factor binding protein IIEF International Index of Erectile Functioning IM intramuscular IMT intima-media thickness IOM Institute of Medicine IPSS International Prostate Symptom Scale IRB institutional review board LDL low-density lipoprotein LH luteinizing hormone LHRH luteinizing hormone-releasing hormone Lp(a) lipoprotein a MMAS Massachusetts Male Aging Study MRFIT Multiple Risk Factor Intervention Trial MNU N-methyl-N-nitrosourea NA not applicable NCI National Cancer Institute

OCR for page 204
Testosterone and Aging: Clinical Research Directions NIA National Institute on Aging NIH National Institutes of Health NR not reported OR odds ratio PAI plasminogen activator inhibitor PCPT Prostate Cancer Prevention Trial PGWB Psychological General Well-Being scale PIN prostate intraepithelial neoplasia PLESS Proscar Long-term Efficacy and Safety Study POMS Profile of Mood States PSA prostate-specific antigen PSDI Positive Symptom Distress Index Q-LES-Q Endicott Quality of Life Enjoyment and Satisfaction Questionnaire RF risk factor RR relative risk RTI Research Triangle Institute SARMs selective androgen receptor modulators SBP systolic blood pressure SD standard deviation SF-36 Short Form 36 item questionnaire SHBG sex hormone-binding globulin SI Système International T testosterone TC testosterone cypionate TE testosterone enanthate TG triglycerides TT total testosterone TU testosterone undecanoate WHI Women’s Health Initiative

Representative terms from entire chapter:

short form